[Recalled] MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO) — Using oncology information system that manages workflow may result in overtreat… | FDA 2025-12-10
This is an official product-safety recall record. Below are the verified details from the issuing authority, in plain language.
Recall details
| Product | MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO) |
|---|---|
| Brand / manufacturer | Elekta, Inc. |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-1078-2026 |
| Country of notice | United States |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 10 December 2025 |
| EAN / barcode | 07340201500026 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice
This Class II recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from Elekta, Inc.
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.
- Best Snack for Families: Healthy, Nutritious, and Easy to Prepare
- Top Medical Devices of 2024: Innovation for Better Health
- Complete Buying Guide for Dairy Products – Making Informed Choices at the Supermarket
- Was ist (1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene (CAS 135821-03-3)? Sicherheit, Regulierung & Perspektive EU/USA/K
- Qu'est-ce que 1,7,7-trimethyl-3-(phenylmethylene)bicyclo[2.2.1]heptan-2-one (CAS 15087-24-8) ? Sécurité, réglementation & perspective UE/États-Unis/Canada | ProductGuru
- Qu'est-ce que 2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone (CAS 119313-12-1) ? Sécurité, réglementation & perspective UE/États-Unis/Canada | ProductGuru